Document:

EX-10.1

 EXHIBIT 10.1 
  

					
	

	  	 Proposal: Placement
Agreement
  
 The Alternative Investment Store, division of
Benjamin & Jerold Brokerage I, LLC.
  
 for

 
 CannaPharmaRX, Inc

 
	  	

 Prepared for: Gerald Crocker CEO & Gary Herick Director of Finance | CannaPharmaRX, Inc. One Collins Drive, Salem
Business Center, Carneys Point, NJ 08069-3640 | Phone: 720.939.1133 | Email: gherick@cpharmarx.com 
 Prepared by: Troy R Vanderburg Chief Executive
Officer, Alternative Investment Store division of Benjamin & Jerold Brokerage I, LLC located at: 80 Broad Street, 6th Floor, New York, NY 10004. 

Description: CannaPharmaRX, Inc. is seeking to raise up to $6,000,000 in Convertible Notes from “Accredited Investors” adherent to a
Private Placement Memorandum under Rule 506 of the Securities Act of 1934. This capital placement will be used to capitalize CannaPharmaRX, Inc. for the intended uses of (1) pursuing the business plan and (2) for funds to acquire and
operate the “Ward Rd.” Pharmacy, and (3) for general working capital. 
 Executive Overview 

The purpose of this proposal is to forge a strategic relationship between CannaPharmaRX, Inc. and the Alternative Investment Store, whereby the Alternative
Investment Store will syndication, introduction, and capital raising services to CannaPharmaRX, Inc. The Alternative Investment Store will act as a introducing broker for CannaPharmaRX, Inc. and provide a best effort in distributing the private
offering to Registered Investment Advisors, Broker Dealers and their Accredited Investors, Private Family Offices, Hedge Funds, Private Equity Funds, and other Institutional Investors. 

The Alternative Investment Store shall focus its efforts on providing CannaPharmaRX, Inc. with three main services: 

New Business Development: This includes all stages of the sales process from the initial introduction until 

 
the subscription documents are signed. External sales professionals representing the Alternative Investment Store and affiliates or partners of the Alternative Investment Store will focus their
prospecting efforts on Registered Investment Advisor Firms, Broker Dealers, and Institutional Investors in markets identified by the executive team of the Alternative Investment Store. Their activities will consist of phone calls, webinars, advisor
workshops and advisor/client private workshops. The executive teams at both firms shall discuss the activity reports at the discretion or request of CannaPharmaRX, Inc. executive leadership. 

Financial Intermediary Relations: This service includes building and maintaining relationships with staff members involved at every stage of the
process. This includes the research analysts who approve products to the, field consultants, and senior advisors who work directly with clients and assist them with manager selection. 

Marketing Support: All support and services required to aid in the generation of new business, including consulting with CannaPharmaRX, Inc. on the
development of marketing material such as presentations, brochures, video and white papers. Most of these services are complimentary under our placement agreement; however, the creation of video and content generation is provided at a nominal fee.

 Sales and Marketing Strategy: 
 The external sales
team of the Alternative Investment Store is expected to implement the sales and marketing strategy developed by the executive team. Each member of the external sales team is provided with lists of Registered Investment Advisors and Registered
Representatives who place their client’s assets in alternative investments. Furthermore, each member has existing relationships with Registered Investment Advisors and Registered Representatives who have previously placed client assets in
alternative investment opportunities. 
 External sales professional’s contact Advisors in their territory to identify which advisors work with
accredited investors, how much money do they place in alternatives per year and which alternatives are those advisors currently investing. Based on these phone interviews, the Alternative Investment Store creates a focus list of advisors who will be
invited to an advisor workshop series in which CannaPharmaRX, Inc. will be invited to speak. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 While the external sales force is working on the advisor workshops, Chief Executive Officer, Troy Vanderburg will
be contacting the Chief Investment Officers of private investment funds to schedule in-person visits for himself and the executive team of CannaPharmaRX, Inc. The purpose behind this strategy is to identify larger pools of investments of no less
than $1 million. 
 At the advisor workshops, an executive member of CannaPharmaRX, Inc. will speak to an audience of approximately 8-12 investment
advisors. From this workshop, the goal is to identify 2-3 advisors interested in having the executive team of CannaPharmaRX, Inc. speak to their clients directly at private client workshops. 

In addition to their efforts to drive advisors to the events, our external sales team will be meeting with advisors within their territory on a regular basis.
While at their meeting, the external sales member will invite the advisor to attend an upcoming conference call (schedule to be determined) in which an executive member of CannaPharmaRX, Inc. will speak about the opportunity. 

From these conference calls, the external sales members will identify those advisors interested in speaking with CannaPharmaRX, Inc. directly. For those
advisors with the capacity to do greater than $2.0 million, we will suggest that they fly into Colorado or New Jersey to meet with the executive team of CannaPharmaRX, Inc. and complete further on site Due Diligence. The Alternative Investment
Store, and its affiliates, hereinafter referred to as “AIS” or the “Consultant”, has been retained to serve as a marketing consultant to CannaPharmaRX, Inc. (OTCBB Ticker GDHC—New Ticker Forthcoming) (the
“Client” or the “Company”), on a non-exclusive basis. 
 Time Frame: 12
Months. This agreement shall have a term of twelve months from the date hereof. 
 Capital Raising Best Efforts: $6 Million. 

Fee: 8% cash of all capital raised related in any way to the efforts of the Alternative Investment Store or its subsidiaries plus additional compensation
in the form of Warrants or Common Stock as referenced immediately below, and in Exhibit A. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

	1.	Advisory Fee: AIS will charge a reduced monthly advisory fee and has agreed to payment of $3500.00 for a period of 3 months— and 25,000 shares per month for 3 months commencing as of the date of this contract.

  

	2.	Capital Raising Fee: to include Wholesalers and Outside Broker Dealers: 

 For the
purpose of clarity and to define the agreement as a whole, CannaPharmaRX, Inc. agrees to pay Alternative Investment Store in the case of a Non-Change of Control Transaction the following: 

 

	(i)	For all Equity: a cash fee of eight percent (8%) of the total amount of all equity (or debt) raised by Consultant in an initial financing transaction. If the transaction is done in house, without the use
of an outside Broker dealer, the fee will be a cash fee of Five percent (5%) of the total amount of all equity (or debt) raised by Consultant in an initial financing transaction. 

In Addition: 
  

	(ii)	Upon the execution of this agreement, 25,000 shares of newly issued restricted rule 144 shares of Common Stock. 

  

	(iii)	Warrants for 8% (If the transaction is done in house, without the use of an outside Broker Dealer 5%) of the aggregate total raised— with an exercise price of $2.00 per share, with each Warrant
exercisable for five (5) years from the date this agreement is executed, in the form of the Option Agreement annexed as Exhibit A. 

  

	(iv)	Follow on: a fee payable in cash or warrants (at the discretion of AIS) of five percent (5%) of any additional equity and / or debt from the same or new Prospect(s) raised by Consultant after closing of first
transaction up to an additional thirty six (36) month period. 

 Marketing: CannaPharmaRX, Inc. is given a commitment by Alternative
Investment Store not to charge an additional marketing participation fee. However, CannaPharmaRX, Inc. may consider participation of approximately $3,000 per quarter for events sponsorship related to its Candidates, Advisors and their respective
clients. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
AIS agrees to make reasonable efforts to organize a meetings with Financial Advisory Firms and Institutional Candidates. Client hereby agrees that in the event it engages in a Business
Opportunity with any Candidate, brought specifically on or through the direct efforts of AIS and its affliates, Client will pay a Transaction Fee to AIS according to the following paragraphs below. 

(a) In connection with the agreement described in the Fee: section above, AIS may, from time to time, bring the Company in contact with persons,
whether individuals or entities, that may be suitable candidates to purchase substantially all of the stock or assets of the Company and/or such Subsidiary, to have substantially all of its stock or assets purchased by the Company or such
Subsidiary, to merge with the Company or such Subsidiary, or to enter into a joint venture or other transaction with the Company or such Subsidiary (each, an “M&A Transaction”). If, during the term hereof, the Company or any of
its Subsidiaries enters into an agreement with any such persons or their affiliates, or with any persons introduced to the Company or any of its Subsidiaries or affiliates by any such persons or their affiliates, pursuant to which the Company or any
of its Subsidiaries enters into an M&A Transaction, or if the Company or any of its Subsidiaries enters into an M&A Transaction with any of the foregoing persons within one year following any termination of the term of this agreement, the
Company shall pay to the Consultant, in accordance with the formula set forth below, compensation based on the aggregate value of the consideration, whether in cash, securities, assumption of (or purchase subject to) debt or liabilities (including,
without limitation, indebtedness for borrowed money, pension liabilities and guarantees), or other property, obligations or services, paid or payable, directly or indirectly (in escrow or otherwise), or otherwise assumed in connection with such
M&A Transaction (the “Consideration”). 
 The compensation to be paid shall be paid upon the closing of the M&A Transaction (except
that, if any part of the Consideration is in the form of contingent payments to be calculated by reference to uncertain future occurrences, such as future financial or business performance, then the portion of the fees of the Consultant relating to
such part of the Consideration shall be payable at the earlier of (i) the receipt or payment of such Consideration or (ii) the time that the amount of such Consideration can be determined), by certified check or wire transfer of
immediately available funds, in the following amounts: 10% of the first $5 million of the Consideration; 5% of the Consideration in excess of $5 million up to $ 20 million and 2% over $20 million and 1% over $100,000,000.

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
`For the purposes hereof, with respect to any person or entity, the term “Subsidiary” shall mean any corporation, limited liability company or other entity of which more than 20%
of the total voting power of shares of stock (or equivalent ownership or controlling interest) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is, at the time, owned
or controlled, directly or indirectly, by that person or entity or one or more subsidiaries of that person or entity, or a combination thereof, either on or after the date hereof. 

Syndication Service. 
 The Consultant’s syndication
services will begin with distribution of Company corporate imaging and research, in the sponsorship of Company presentations, through Consultant’s membership in, or association with, several investment banking or investor related organizations
including: 
 Each association represents substantial numbers of industry contacts, institutions, brokers, analysts and investors. The Consultant will serve
as “Company Sponsor” to these organizations, and at the request of the Company, will be scheduled and guided through the process of presentation and follow-up. We may also, from time to time, organize and conduct traditional road shows,
broker luncheons, and/or investor presentations, and may further utilize certain technologies including virtual road shows, teleconferencing for added convenience and ability to reach large audiences. 

The syndication services described in this section will typically involve additional fees, costs and/or expenses on behalf of the Company for participation in
such events, or to engage services from outside vendors introduced by us. Compensation under this Agreement is for the Consultant’s time, contacts, memberships, and marketing services provided. Compensation under this Agreement is not inclusive
of conference fees, T & E expenses, meals, lodging, printing or publication costs, postage, or outside service provider’s fees. Any such fees or expenses shall only be incurred at the written request of the Company, on a case-by-case basis,
and shall be paid by the Company, or reimbursed to Consultant by the Company. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 Available Time. 

The Consultant shall make available such time as it, in its sole discretion, shall deem appropriate for the performance of its obligations under this agreement
and may, in certain circumstances, be entitled to additional compensation in connection therewith. 
 Relationship. 

Nothing herein shall constitute the Consultant as an employee or agent of the Company, except to such extent as might hereinafter agreed upon for a particular
purpose. Except as might hereinafter be expressly agreed, the Consultant shall not have the authority to obligate or commit the Company in any manner whatsoever. 

Entire Agreement. 
 This agreement, including the
schedules and exhibits hereto, contains the entire agreement of the parties and supersedes all other agreements and understandings, oral or written, with respect to the matters contained herein. 

No Waiver. 
 No act, omission or delay by the Consultant
shall constitute a waiver of its rights and remedies hereunder or otherwise. No single or partial waiver by the Consultant of any default, right or remedy that it may have shall operate as a waiver of any other default, right or remedy, or of the
same default, right or remedy on a future occasion. 
 Assignment. 

This agreement shall be binding upon and inure to the benefit of the respective heirs, representatives, successors and assigns of the parties hereto,
provided; however, that this agreement may not be assigned by the Company without the prior written consent of the Consultant; provided, further, however, that the 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
Consultant may assign its rights and delegate its duties under this agreement to any affiliate of the Consultant without the consent of the Company. As used in the preceding sentence, the term
“affiliate” shall have the meaning set forth in Rule 12b-2 of the General Rules and Regulations promulgated under the Exchange Act. 

Waiver of Jury Trial and Setoff; Consent to Jurisdiction; Etc. 

(a) In any litigation in any court with respect to, in connection with, or arising out of this agreement or any instrument or document delivered pursuant to
this agreement, or the validity, protection, interpretation, collection or enforcement hereof or thereof, or any other claim or dispute howsoever arising, between the Company, on the one hand, and the Consultant on the other hand, the Company, to
the fullest extent it may legally do so, (i) waives the right to interpose any setoff, recoupment, counterclaim or cross-claim in connection with any such litigation, irrespective of the nature of such
setoff, recoupment, counterclaim or cross-claim, unless such setoff, recoupment, counterclaim or cross-claim could not, by reason of any applicable federal or state procedural laws, be interposed, pleaded or alleged in any other action and
(ii) waives trial by jury in connection with any such litigation and any right it may have to claim or recover in any such litigation any special, exemplary, punitive or consequential damages or any damages other than, or in addition to, actual
damages. The company agrees that this section 9(a) is a specific and material aspect of this agreement and acknowledges that the consultant would not enter into this agreement if this section 9(a) were not part of this agreement. 

(b) The Company hereby irrevocably consents to the exclusive jurisdiction of any State or Federal Court located within the County of Maricopa, State of
Arizona, in connection with any action or proceeding arising out of or relating to this agreement or any document or instrument delivered pursuant to this agreement or otherwise. In any such litigation, the Company waives, to the fullest
extent it may effectively do so, personal service of any summons, complaint or other process and agrees that the service thereof may be made by certified or registered mail directed to the Company, at its address on the first page hereof. The
Company hereby waives, to the fullest extent it may effectively do so, the defenses of forum non conveniens and improper venue. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 Governing Law. 

This agreement shall be deemed to be a contract made under the laws of the State of Arizona and for all purposes shall be construed in accordance with the laws
of said State. 
 Indemnity. 
 The Company agrees to
indemnify the Consultant, its affiliates and all related persons, in accordance with the indemnification rider annexed hereto as Schedule A, the provisions of which are incorporated herein in their entirety. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 SCHEDULE A 

INDEMNIFICATION 
 Recognizing
that matters of the type contemplated in this engagement sometimes result in litigation and that our role is marketing, the Company agrees to indemnify and hold harmless AIS, its affiliates and their respective officers, directors, employees, agents
and controlling persons (collectively, the “Indemnified Parties”), from and against any losses, claims, damages and liabilities, joint or several, related to or arising in any manner out of any transaction, financing, proposal or
any other matter (collectively, the “Matters”) contemplated by the engagement of AIS hereunder, and will promptly reimburse the Indemnified Parties for all expenses (including fees and expenses of legal counsel) as incurred in
connection with the investigation of, preparation for or defense of any pending or threatened claim related to or arising in any manner out of any Matter contemplated by the engagement of AIS hereunder, or any action or proceeding arising therefrom
(collectively, “Proceedings”), whether or not such Indemnified Party is a formal party to any such Proceeding. Notwithstanding the foregoing, the Company shall not be liable in respect of any losses, claims, damages, liabilities or
expenses that a court of competent jurisdiction shall have determined by final judgment resulted solely from the gross negligence or willful misconduct of an Indemnified Party. The Company further agrees that it will not, without the prior written
consent of AIS, settle, compromise or consent to the entry of any judgment in any pending or threatened Proceeding in respect of which indemnification may be sought hereunder (whether or not AIS or any Indemnified Party is an actual or potential
party to such Proceeding), unless such settlement, compromise or consent includes an unconditional release of AIS and each other Indemnified Party hereunder from all liability arising out of such Proceeding. In addition, AIS agrees that it will not
settle, compromise or consent to the entry of any judgment in any pending or threatened Proceeding in respect of which indemnification is sought under this Agreement, without the prior written consent of the Company, which consent shall not be
unreasonably withheld, delayed or conditioned. 
 The Company agrees that if any indemnification or reimbursement sought pursuant to this
letter is held by a court for any reason to not be available to any Indemnified Party or insufficient to hold it harmless as and to the extent contemplated by this letter, then the Company shall contribute to the amount paid or payable by such
Indemnified Party in respect of losses, claims, damages and liabilities in 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
such proportion as is appropriate to reflect the relative benefits to the Company and its stockholders on the one hand, and AIS on the other, in connection with the Matters to which such
indemnification or reimbursement relates or, if such allocation is not permitted by applicable law, not only such relative benefits but also the relative faults of such parties to the Company and/or its stockholders and to AIS with respect to
AIS’s engagement shall be deemed to be in the same proportion as (i) the total value paid or received or to be paid or received by the Company and/or its stockholders pursuant to the Matters (whether or not consummated) for which AIS is
engaged to render financial marketing services bears to (ii) the fees paid to AIS in connection with such engagement. In no event shall the Indemnified Parties contribute or otherwise be liable for an amount in excess of the aggregate amount of
fees actually received by AIS pursuant to such engagement (excluding amounts received by AIS as reimbursement of expenses). 
 The
indemnity, reimbursement and contribution provisions set forth herein shall remain operative and in full force and effect regardless of (i) any withdrawal, termination or consummation of or failure to initiate or consummate any Matter referred
to herein, (ii) any investigation made by or on behalf of any party hereto or any person controlling (within the meaning of Section 15 of the Securities Act of 1933, as amended, or Section 20 of the Exchange Act) any party hereto,
(iii) any termination or the completion or expiration of this letter or AIS’s engagement and (iv) whether or not AIS shall, or shall not be called upon to, render any formal or informal advice in the course of such engagement. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 EXHIBIT A 

OPTION AGREEMENT 
 OPTION AGREEMENT (this
“Agreement”), dated December 11th 2014, between Alternative Investment Store a division of Benjamin & Jerold Brokerage I, LLC (the “Grantee”), and
CannaPharmaRX, Inc. 
 One Collins Drive, Salem Business Center, Carneys Point, NJ 08069-3640 a Delaware Corporation. 

(OTCBB GDHC New Ticker Forthcoming) (the “Company”). 

WHEREAS, the Company has authorized 100,000,000 shares and has issued and outstanding 16,600,000 shares of common stock, par value [$.01] per
share (the “Common Stock”), representing all of the Company’s issued and outstanding shares of capital stock as of the Date of Grant (as hereinafter defined); and 

WHEREAS, concurrently herewith, the Grantee and the Company are entering into a Financial Agreement dated the date hereof (the “Agreement”)
whereby the Grantee agrees to provide to the Company and its subsidiaries the aforementioned services in accordance with the terms and provisions, and subject to the conditions, set forth above; and 

WHEREAS, as partial consideration for the Grantee’s provision of services under the Consulting Agreement, the Company desires to grant to the Grantee,
and the Grantee desires to acquire from the Company, an option to purchase 8% of the Value of Capital Raised in shares of Common Stock and shares, upon and subject to the terms and conditions hereinafter set forth. 

NOW THEREFORE, in consideration of the agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows: 
 Grant of Option. The Company hereby grants to the Grantee a Warrant (the
“Option”) to 8% of the Value of Capital of Common Stock directly from the issuer. Such shares, including any shares issued pursuant to Section 5 hereof, are referred to as the “Option Shares”) as follows
(the “Exercise Price”) of $2.00 per share with each option exercisable for five (5) years from the date this agreement is executed. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

	1.	Term of Option. The Option is granted as of the date first above written (sometimes hereinafter referred to as the “Date of Grant”), and will terminate and expire, to the extent not previously
exercised in accordance with the terms of this Agreement, on the third anniversary of the Date of Grant. 

  

	2.	Option Exercisable in Whole or in Part. The Option may be exercised as to all or part of the shares of Common Stock as to which it is exercisable, but not for a fractional share. 

 

	3.	Exercise of Option. 

 (a) The Grantee may exercise the Option with respect to all or any part of the
number of Option Shares by giving the Company written notice of intent to exercise. The notice of exercise shall specify the number of Option Shares as to which the Option is to be exercised and the date of exercise thereof, which date shall be at
least one business day after the giving of such notice. 
 (b) On the exercise date specified in the Grantee’s notice, the Company shall cause to be
delivered to the Grantee evidence of ownership of the Option Shares then being purchased upon full payment for such Option Shares as provided in Section 3(e) below and shall promptly record such Option Shares on its official records as having
been issued to the Grantee. Pursuant to Section 9 hereof, the Company may require before issuing such evidence of ownership that, at the time of exercise, the Grantee deliver an investment representation. 

(c) In the event that the Grantee exercises the Option for a number of Option Shares less than the total number of Option Shares that the Grantee has a right
to purchase under this Agreement, then the Company shall, if so requested by the Grantee, issue to the Grantee an Option identical in form to this Option but for a number of Option Shares that shall be equivalent to the total number of Option Shares
covered by this Agreement less the number of Option Shares so purchased. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 (d) If the Grantee fails to pay for any of the Option Shares specified in any notice of exercise or fails to
accept delivery thereof, such Option Shares shall not be issued by the Company and shall remain subject to subsequent exercises by the Grantee pursuant to the terms hereof. The date specified in the Grantee’s notice as the date of exercise
shall be deemed the date of exercise of the Option, provided that payment (in accordance with Section 4 below) for the Option Shares to be purchased upon such exercise shall have been received by such date. 

(e) Full payment by the Grantee of the Exercise Price for the number of Option Shares purchased shall be made on or before the exercise date specified in the
notice of exercise, by delivery of, at the option of the Grantee, cash or a full-recourse promissory note (the “Note”) in an amount equal to the Exercise Price for such Option Shares. The Note shall have a maturity date (the
“Maturity Date”) of the three-year anniversary of the execution and delivery thereof. During the term of the Note, interest (which shall accrue at a rate of 8% per annum) shall be payable in arrears, on the last day of March,
November, September and December or, if such day is not a business day, on the next succeeding business day. Principal and all accrued interest shall be paid on the Maturity Date. 

 

	4.	Payments; Cashless Exercise. 

 (a) Payment may be made either in (i) cash or by certified or
official bank check or checks payable to the order of the Company equal to the applicable aggregate Exercise Price, (ii) by delivery of the Note, or (iii) by a combination of any of the foregoing methods for the number of Common Shares
specified in such form, as such exercise number shall be adjusted to reflect any adjustment in the total number of shares of Common Stock issuable to the Grantee per the terms of this Agreement) and the Grantee shall thereupon be entitled to receive
the number of duly authorized, validly issued, fully-paid and non-assessable shares of Common Stock (or Other Securities) determined as provided herein. 

(b) In the circumstances set forth herein, if the Fair Market Value (as hereinafter defined) of one share of Common Stock is greater than the Exercise Price
(at the date of calculation as set forth below), in lieu of exercising the Option for cash the Grantee may elect to receive shares equal to the value (as determined below) of the Option (or the portion thereof being cancelled) by surrender of the
Option at the principal office of the Company in which event the Company shall issue to the Grantee a number of 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
shares of Common Stock calculated, as of the date of exercise, using the following formula: 

X=Y (A-B) 
 A 

Where: 
 X= the number of shares of Common Stock to be issued to
the Grantee 
 Y= the number of shares of Common Stock purchasable under the Option or, if only a portion of the Option is being exercised, the portion of
the Option being exercised (at the date of such calculation) 
 A= the Fair Market Value of one share of the Company’s Common Stock (at the date of
such calculation) 
 B= the Exercise Price (as adjusted to the date of such calculation) 

“Fair Market Value” of a share of Common Stock as of a particular date (the “Determination Date”) shall mean the Fair Market Value
of a share of the Company’s Common Stock. Fair Market Value of a share of Common Stock as of a Determination Date shall mean: 
 (i) if
the Company’s Common Stock is traded on an exchange or is quoted on the National Association of Securities Dealers, Inc. Automated Quotation (“NASDAQ”) Global Market or the NASDAQ Capital Market, then the closing or last sale price,
respectively, reported for the last business day immediately preceding the Determination Date; 
 (ii) if the Company’s Common Stock is
not traded on an exchange or on the NASDAQ Global Market or the NASDAQ Capital Market but is traded in the over-the-counter market, then the closing bid price reported
for the last business day immediately preceding the Determination Date; 
 (iii) except as provided in clause (d) below, if the
Company’s Common Stock is not publicly traded, then as the Grantee and the Company agree or in the absence of agreement by arbitration in accordance with the rules then standing of the American Arbitration Association, before a single
arbitrator to be chosen from a panel of persons qualified by education and training to pass on the matter to be decided; or 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 (iv) if the Determination Date is the date of a liquidation, dissolution or winding up, or any
event deemed to be a liquidation, dissolution or winding up pursuant to the Company’s charter, then all amounts to be payable per share to holders of the Common Stock pursuant to the charter in the event of such liquidation, dissolution or
winding up, plus all other amounts to be payable per share in respect of the Common Stock in liquidation under the charter, assuming for the purposes of this clause (d) that all of the shares of Common Stock then issuable upon exercise of all
of the Options held by the Grantee are outstanding at the Determination Date. 
  

	5.	Adjustment; Recapitalization, etc. 

 (a) If the Company shall (i) declare a dividend on its
outstanding capital stock in shares of its capital stock, (ii) subdivide its outstanding capital stock into a greater number of shares, (iii) combine its outstanding capital stock into a smaller number of shares or (iv) issue any
shares of its capital stock by reclassification thereof (including any such reclassification in connection with a consolidation or merger in which it is the continuing corporation), then in each such case the total number of shares of Common Stock
that may be issued under this Agreement (and the Exercise Price) shall be proportionately adjusted by the Company. Such adjustment shall be made successively whenever such events shall occur. The adjustment shall become effective immediately after
the record date in the case of a dividend or distribution and immediately after the effective date in the case of a subdivision, combination or reclassification. 

(b) If the Company merges or consolidates with one or more companies, then from and after the effective date of such merger or consolidation, upon exercise of
the Option theretofore granted, (i) the Grantee shall be entitled to purchase under the Option, in lieu of the number of shares of Common Stock as to which the Option shall then be exercisable but on the same terms and conditions of exercise
set forth in the Option, the number of shares of Common Stock and/or other securities or property (including cash) to which the Grantee would have been entitled pursuant to the terms of the agreement of merger or

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
consolidation if, immediately prior to such merger or consolidation, the Grantee had been the holder of record of the total number of shares of Common Stock receivable upon exercise of the Option
(whether or not then exercisable) and (ii) the Exercise Price shall be proportionately adjusted by the Company (to reflect any change in the number of securities into which the Option is converted), without a change to the aggregate Exercise
Price payable for all of the Option Shares. 
 (c) All calculations under this Section 5 shall be made to the nearest cent or to the nearest one-hundredth of a share, as the case may be. The number of shares of capital stock outstanding shall be deemed to include the aggregate maximum number of shares issuable upon the exercise of options, rights or
warrants and upon the conversion or exchange of convertible or exchangeable securities. 
 (d) Whenever there shall be an adjustment as provided in this
Section 5, then the Company shall within 10 days thereafter cause written notice thereof to be sent by registered mail, postage prepaid, to the Grantee, which notice shall be accompanied by an officer’s certificate setting forth the number
of Option Shares issuable and the Exercise Price thereof after such adjustment and setting forth a brief statement of the facts requiring such adjustment and the computation thereof. 

(e) The Company shall not be required to issue fractions of shares of capital stock of the Company upon the exercise of this Option. If any fraction of a
shares of capital stock would be issuable on the exercise of this Option (or specified portions thereof), the Company shall purchase such fraction for an amount in cash equal to the same fraction of the Current Market Price of such capital stock on
the date of exercise of this Option. 
 6. Report or Certificate as to Adjustments. In each case of any adjustment or readjustment in the Option
Shares issuable upon the exercise of the Option, the Company at its expense will promptly deliver a certificate of its Chief Financial Officer showing in reasonable detail the computation of such adjustment or readjustment in accordance with the
terms of this Agreement. 
 7. Notices of Corporate Action. In the event of: 

(a) any taking by the Company of a record of the holders of any class of securities for the purpose of 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
determining the holders thereof who are entitled to receive any dividend or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of stock of any class or
any other securities or property, or to receive any other right, or 
 (b) any capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company, any consolidation or merger involving the Company and any other Person or any transfer of all or substantially all the assets of the Company to any other Person, or 

(c) any voluntary or involuntary dissolution, liquidation or winding-up of the Company, or 

(d) any plan or proposal by the Company to register any class of its shares of Common Stock with the Commission, then the Company shall deliver to the Grantee
a notice specifying (i) the date or expected date on which any such record is to be taken for the purpose of such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii) the date or
expected date on which any such reorganization, reclassification, recapitalization, consolidation, merger, transfer, dissolution, liquidation or winding-up is to take place and the time, if any such time is to
be fixed, as of which the Grantee shall be entitled to exchange the Option Shares for the securities or other property deliverable upon such reorganization, reclassification, recapitalization, consolidation, merger, transfer, dissolution,
liquidation or winding-up. Such notice shall be furnished at least 30 days prior to the date therein specified. 
  

	8.	Registration Rights. 

 8.1 Piggyback Registration. If the Company at any time proposes to register
any of its securities under the Securities Act for sale to the public, whether for its own account or for the account of other security holders or both (except with respect to registration statements on Forms S-4, S-8 or another form not available
for registering the Registrable Stock, as hereinafter defined, for sale to the public), each such time it will give written notice to all holders of outstanding Registrable Stock of its intention so to do. Upon the written request of any such
holder, received by the Company within 30 days after the giving of any such notice by the Company, to register any of its Registrable Stock, the Company will cause the Registrable Stock as to which registration shall have been so requested to be
included in the securities to 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
be covered by the registration statement proposed to be filed by the Company, all to the extent requisite to permit the sale or other disposition by the holder (in accordance with its written
request) of such Registrable Stock so registered. In the event that any registration pursuant to this Section 8.1 shall be, in whole or in part, an underwritten public offering of Common Stock by the Company, the number of shares of Registrable
Stock to be included in such an underwriting shall be reduced (pro rata among the requesting holders and any other holders of Common Stock who are registering such Common Stock pursuant to registration rights granted prior to the date hereof,
based upon the number of shares each requesting holder and each such other holder has proposed to include in such registration) if and to the extent that the managing underwriter shall be of the opinion that such inclusion would adversely affect the
marketing of the securities to be sold by the Company therein; provided, however, that the Company shall cause all of the Registrable Stock of any requesting holder to be registered before causing any Common Stock not subject to
registration rights granted prior to the date hereof to be registered. Notwithstanding the foregoing provisions, the Company may withdraw any registration statement referred to in this Section 8.1 without thereby incurring any liability to the
holders of Registrable Stock. The Company shall be obligated to register Registrable Stock under this Section 8.1 an unlimited number of times; provided, however, that such obligation shall be deemed satisfied only when a
registration statement covering all shares of Registrable Stock specified in written requests received as aforesaid, for sale in accordance with the method of disposition specified by the requesting holders, shall have become effective and, if such
method of disposition is a firm commitment underwritten public offering, all such shares shall have been sold pursuant thereto. For purposes of this Agreement, “Registrable Stock” shall mean all of the Option Shares, and any and all
other shares of Common Stock held by or issuable to Grantee including, without limitation, any Option Shares issuable (but not yet issued) upon exercise of this Option, excluding Option Shares that (i) have been registered under the Securities
Act pursuant to an effective registration statement filed thereunder and disposed of in accordance with the registration statement covering them, (ii) have been publicly sold pursuant to Rule 144 under the Securities Act, or (iii) are
otherwise publicly tradable, without registration, pursuant to any other applicable exemption from registration under the Securities Act. 
 8.2
Expenses. All expenses incurred by the Company’s in complying with Section 8.1, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel and independent public accountants
for the Company, fees and expenses (including counsel fees) incurred in 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
connection with complying with state securities or “blue sky” laws, fees of the securities exchange upon which the Common Stock is then listed, transfer taxes, fees of transfer agents
and registrars, costs of any insurance which might be obtained, and the reasonable fees and disbursements of one counsel to the sellers of Registrable Stock, but excluding any Selling Expenses (as defined below), are called “Registration
Expenses.” All underwriting discounts and selling commissions applicable to the sale of Registrable Stock are called “Selling Expenses.” 

The Company shall pay all Registration Expenses in connection with each registration statement under Section 8.1. All Selling Expenses in connection with
each registration statement under Section 8.1 shall be borne by the participating sellers in proportion to the number of shares sold by each, or by such participating sellers, other than the Company (except to the extent the Company shall be a
seller), as they may agree. 
  

	8.3	Indemnification and Contribution. 

 (a) In the event of a registration of any of the Registrable Stock
under the Securities Act pursuant to Section 8.1, the Company will indemnify and hold harmless each seller of such Registrable Stock thereunder, its officers and directors, each underwriter of such Registrable Stock thereunder and each other
person, if any, who controls such seller or underwriter within the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which such seller, officer, director, underwriter or controlling person may
become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of any material
fact contained in any registration statement under which such Registrable Stock was registered under the Securities Act pursuant to Section 8.1, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement
thereof, (ii) any blue sky application or other document executed by the Company specifically for that purpose or based upon written information furnished by the Company filed in any state or other jurisdiction in order to qualify any or all of
the Registrable Stock under the securities laws thereof (any such application, document or information herein called a “Blue Sky Application”), (iii) the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading, (iv) any violation by the Company or its agents of any rule or regulation 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
promulgated under the Securities Act applicable to the Company or its agents and relating to action or inaction required of the Company in connection with such registration, or (v) any
failure to register or qualify the Registrable Stock in any state where the Company or its agents has affirmatively undertaken or agreed in writing that the Company (the undertaking of any underwriter chosen by the Company being attributed to the
Company) will undertake such registration or qualification on the seller’s behalf (provided that in such instance the Company shall not be so liable if it has undertaken its best efforts to so register or qualify the Registrable Stock) and will
reimburse each such seller, and such officer and director, each such underwriter and each such controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage,
liability or action; provided, however, that the Company will not be liable in any such case if and to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue
statement or omission or alleged omission so made in conformity with information furnished by any seller of Registered Stock, any such underwriter or any such controlling person in writing specifically for use in such registration statement or
prospectus. 
 (b) In the event of a registration of any of the Registrable Stock under the Securities Act pursuant to Section 8.1, each seller of such
Registrable Stock thereunder, severally and not jointly, will indemnify and hold harmless the Company, each person, if any, who controls the Company within the meaning of the Securities Act, each officer of the Company who signs the registration
statement, each director of the Company, each other seller of Registrable Stock, each underwriter and each person who controls any underwriter within the meaning of the Securities Act, against all losses, claims, damages or liabilities, joint or
several, to which the Company or such officer, director, other seller, underwriter or controlling person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement under which such Registrable Stock was registered under the Securities Act pursuant to Section 8.1, any
preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereof, or any Blue Sky Application or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and will reimburse the Company and each such officer, director, other seller, underwriter and controlling person for any legal or other expenses reasonably incurred by them
in connection with investigating or defending any such loss, 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
claim, damage, liability or action; provided, however, that such seller will be liable hereunder in any such case if and only to the extent that any such loss, claim, damage or
liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with information pertaining to such seller, as such, furnished in writing to the Company
by such seller specifically for use in such registration statement or prospectus; and provided, further, however, that the liability of each seller hereunder shall be limited to the proportion of any such loss, claim, damage,
liability or expense which is equal to the proportion that the public offering price of the shares sold by such seller under such registration statement bears to the total public offering price of all securities sold thereunder, but not in any event
to exceed the proceeds received by such seller from the sale of Registrable Stock covered by such registration statement. Not in limitation of the foregoing, it is understood and agreed that the indemnification obligations of any seller hereunder
pursuant to any underwriting agreement entered into in connection herewith shall be limited to the obligations contained in this paragraph (b). 
 (c)
Promptly after receipt by an indemnified party hereunder of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party
in writing thereof, but the omission so to notify the indemnifying party shall not relieve it from any liability which it may have to such indemnified party other than under this Section 8.3 and shall only relieve it from any liability which it
may have to such indemnified party under this Section 8.3 if and to the extent the indemnifying party is prejudiced by such omission. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying
party of the commencement thereof, the indemnifying party shall be entitled to participate in and, to the extent it shall wish, to assume and undertake the defense thereof with counsel satisfactory to such indemnified party, and, after notice from
the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying party shall not be liable to such indemnified party under this Section for any legal expenses subsequently incurred by
such indemnified party in connection with the defense thereof other than reasonable costs of investigation and of liaison with counsel so selected; provided, however, that, if the defendants in any such action include both the
indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be reasonable defenses available to it which are different from or additional to those available to the indemnifying party or if
the interests of the indemnified party reasonably may be deemed 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
to conflict with the interests of the indemnifying party, the indemnified party shall have the right to select a separate counsel and to assume such legal defenses and otherwise to participate in
the defense of such action, with the expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the indemnifying party as incurred. 

(d) In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in which either (i) any holder of
Registrable Stock exercising rights under this Agreement, or any controlling person of any such holder, makes a claim for indemnification pursuant to this Section 8.3 but it is judicially determined (by the entry of a final judgment or decree
by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Section 8.3 provides for
indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any such selling holder or any such controlling person in circumstances for which indemnification is provided under this
Section 8.3; then, and in each such case, the Company and such holder will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in such proportions so that such holder
is responsible for the portion represented by the percentage that the public offering price of its Registrable Stock offered by the registration statement bears to the public offering price of all securities offered by such registration statement,
and the Company is responsible for the remaining portion; provided, however, that, in any such case, (A) no such holder will be required to contribute any amount in excess of the public offering price of all such Registrable Stock
offered by it pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person or
entity who was not guilty of such fraudulent misrepresentation. 
 (e) The indemnities provided in this Section 8.3 shall survive the transfer of any
Registrable Stock by such holder. 
 9. Requirements of Law. The Company shall not be required to sell or issue any Option Shares upon the exercise
of the Option if the issuance of such Option Shares shall constitute a violation by the Grantee or the Company of any provision of any law, statute, or regulation of any governmental authority whether it be Federal or State. Unless a registration
statement is in effect under the Securities Act with 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
respect to the Option Shares covered by this Agreement, the Company shall not be required to issue Option Shares upon exercise of the Option unless (i) the Company has received evidence
reasonably satisfactory to it to the effect that the Grantee is acquiring such Option Shares for investment and not with a view to the distribution thereof; or (ii) an opinion of Troutman Sanders LLP or such other counsel reasonably acceptable
to the Company has been received by the Company, in a form and substance reasonably acceptable to the Company, to the effect that a registration statement under the Securities Act is not required for the issuance of the Option Shares. In the event
the Option Shares issuable upon exercise of the Option are not registered under the Securities Act, the Company may imprint on any evidence of ownership of the Option Shares the following legend or any other legend that counsel for the Company
considers necessary or advisable to comply with the Securities Act: 
 “THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT, OR PURSUANT TO AN EXEMPTION
FROM REGISTRATION UNDER THE ACT.” 
 Except as otherwise provided in Section 8 hereof: (i) the Company may, but in no event
shall be obligated to, register any securities issuable upon the exercise of the Option pursuant to the Securities Act or any state securities laws and, in the event any shares are so registered, the Company may remove any legend on certificates
representing such shares; and (ii) the Company shall not be obligated to take any affirmative action in order to cause the exercise of the Option or the issuance of Option Shares pursuant thereto to comply with any law or regulation of
governmental authority. 
 10. Representations and Warranties of the Company. Company represents and warrants as follows: 

(a) The Company is a [corporation] duly organized, validly existing and in good standing under the laws of the State of Delaware; 

(b) Upon the delivery and payment for the Option Shares, as provided in this Agreement, the Option Shares will be duly authorized, validly
issued and non-assessable, and none of the Option Shares will be issued in violation of the preemptive rights of any member of the Company, and the Company has reserved sufficient Option Shares for issuance hereunder; and 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 (c) This Agreement has been duly authorized, executed and delivered by the Company. 

The foregoing representations and warranties shall survive and remain in full force and effect after the date hereof and shall not affect the validity or
enforceability of any representations, warranties and agreements made by the Company herein. 
 11. Reservation of Stock, etc. The Company will at
all times reserve and keep available, solely for issuance and delivery upon the exercise of the Options, the number of Option Shares from time to time issuable upon the exercise of the Option. All such securities shall be duly authorized and, when
issued upon such exercise or purchase, as the case may be, shall be validly issued and, in the case of shares, fully paid and non-assessable with no liability on the part of the holders thereof. 

12. Rights as Stockholder. The Grantee shall not have any rights of a stockholder of the Company with respect to Option Shares subject to this
Agreement, until, after proper exercise of the Option, such Option Shares have been recorded on the Company’s official records as having been issued or transferred to the party exercising the Option. No adjustment shall be made for dividends or
other rights for which the record date is prior to the date such shares are recorded as issued or transferred (to the party exercising the Option) in the Company’s official records, except as provided in Section 5. 

13. Certain Definitions. As used herein, unless the context otherwise requires the following terms have the following respective meanings:
(i) “Commission” shall mean the Securities and Exchange Commission or any other Federal agency at the time administering the Securities Act; (ii) “Exchange Act” shall mean the Securities Exchange Act of
1934, or any similar Federal statute, and the rules and regulations of the Commission there under, all as the same shall be in effect at the time; (iii) “Person” shall mean a corporation, an association, a partnership, an
organization or business, an individual, a government or political subdivision thereof or a governmental agency; (iv) “Securities Act” shall mean the Securities Act of 1933, or any similar Federal statute on the rules and
regulations of the Commission thereunder, all as the same shall be in effect at the time; and (v) the term “affiliate” shall have the meaning set forth in Rule 12b-2 of the General Rules and Regulations promulgated under the
Exchange Act, as amended. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

	14.	Miscellaneous. 

 (a) Governing Law. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of Arizona without regard to principles of conflicts or choice of law (or any other law that would make any substantive laws of any state other than the State of Arizona (applicable
hereto). 
 (b) Waiver of Jury Trial and Setoff; Consent to Jurisdiction; Etc. 

(i) In any litigation in any court with respect to, in connection with, or arising out of this Agreement or any instrument or document delivered pursuant to
this Agreement, or the validity, protection, interpretation, collection or enforcement hereof or thereof, or any other claim or dispute howsoever arising, between the Company and the Grantee, the Company, to the fullest extent it may legally do so,

 (i) waives the right to interpose any setoff, recoupment, counterclaim or cross-claim in connection with
any such litigation, irrespective of the nature of such setoff, recoupment, counterclaim or cross-claim, unless such setoff, recoupment, counterclaim or cross-claim
could not, by reason of any applicable federal or state procedural laws, be interposed, pleaded or alleged in any other action and (ii) WAIVES TRIAL BY JURY IN CONNECTION WITH ANY SUCH LITIGATION AND ANY RIGHT IT MAY HAVE TO CLAIM OR RECOVER
IN ANY SUCH LITIGATION ANY SPECIAL, EXEMPLARY, PUNITIVE OR CONSEQUENTIAL DAMAGES OR ANY DAMAGES OTHER THAN, OR IN ADDITION TO, ACTUAL DAMAGES. THE COMPANY AGREES THAT THIS SECTION 14(b) IS A SPECIFIC AND MATERIAL ASPECT OF THIS AGREEMENT AND
ACKNOWLEDGE THAT THE GRANTEE WOULD NOT ENTER THIS AGREEMENT OR THE TRANSACTIONS OF WHICH THIS AGREEMENT IS A PART IF THIS SECTION 14(b) WERE NOT PART OF THIS AGREEMENT. 

(ii) The Company hereby irrevocably consents to the exclusive jurisdiction of any State or Federal Court located within the County of Maricopa, State of
Arizona, in connection with any action or proceeding 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 
arising out of or relating to this Agreement or any document or instrument delivered pursuant to this Agreement or otherwise. In any such litigation, the Company waives, to the fullest extent it
may effectively do so, personal service of any summons, complaint or other process and agrees that the service thereof may be made by certified or registered mail directed to the Company at its address for notice determined in accordance with
Section 14(e) hereof. The Company hereby waives, to the fullest extent it may effectively do so, the defenses of forum non conveniens and improper venue. 

(c) Expenses. The Company agrees to pay or reimburse within 30 days of demand therefore by the Grantee any and all reasonable out-of-pocket costs and expenses incurred by the Grantee, whether directly or indirectly, in connection with the enforcement and adjudication of this Agreement, the Option or
rights created under any documents executed in connection herewith. The Grantee shall endeavor to provide reasonable documentation in connection with any demand for payment under this Section. 

(d) Admissibility of the Agreement. The Company agrees that any copy of this Agreement signed by the Company and transmitted by
tele-copier for delivery to the Grantee shall be admissible in evidence as the original itself in any judicial or administrative proceeding, whether or not the original is in existence. 

(e) Address for Notices. Any notice or other communication under the provisions of this Agreement shall be given in writing and
delivered in person, by reputable overnight courier or delivery service, by facsimile machine (receipt confirmed) or by registered or certified mail, return receipt requested, directed to its addresses set forth below (or to any new address of which
either party hereto shall have informed the other by the giving of notice in the manner provided herein): 
  

			
	In the case of the Grantee:	  	Alternative Investment Store, LLC
		  	Division of Benjamin & Jerold Brokerage I, LLC
		  	Attention: Terry Dolan
		  	80 Broad Street, 5th Floor, #526
		  	New York, New York 85203

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

			
	In the case of the Company:	  	CannaPharmaRX, Inc.
		  	Attention: Gary Herick
		  	One Collins Drive,
		  	Salem Business Center,
		  	Carneys Point, NJ 08069

 (f) Amendments and Modification. No provision hereof shall be modified, altered, waived or limited
except by written instrument expressly referring to this Agreement and to such provision, and executed by the parties hereto. 
 (g)
Counterparts. This Agreement may be executed by the parties hereto individually or in any combination, in one or more counterparts, each of which shall be an original and all of which shall together constitute one and the same agreement. 

(h) Captions. The captions of the various sections and paragraphs of this Agreement have been inserted only for the purposes of
convenience; such captions are not a part of this Agreement and shall not be deemed in any manner to modify, explain, enlarge or restrict any of the provisions of this Agreement. 

(i) Severability. In the event that any term or provision of this Agreement shall be finally determined to be superseded, invalid,
illegal or otherwise unenforceable pursuant to applicable law by an authority having jurisdiction and venue, that determination shall not impair or otherwise affect the validity, legality or enforceability (i) by or before that authority of the
remaining terms and provisions of this Agreement, which shall be enforced as if the unenforceable term or provision were deleted, or (ii) by or before any other authority of any of the terms and provisions of this Agreement. 

(j) Entire Agreement. This Agreement contains the entire agreement of the parties and supersedes all other agreements and
understandings, oral or written, with respect to the matters contained herein. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by all parties. 

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

 (k) Successors and Assignments. This Agreement shall be binding upon and inure to the
benefit of the respective heirs, representatives, successors and assigns of the parties hereto, provided that this Agreement may not be assigned by the Company without the prior written consent of the other party hereto and may be assigned by the
Grantee to an affiliate of the Grantee without the consent of Acquisition Sub. 
 IN WITNESS WHEREOF, the parties hereto have signed this Agreement as of
the date first above written. THIS CONTRACT CONTAINS A BINDING ARBITRATION PROVISION THAT MAY BE ENFORCED BY THE PARTIES. 
 WITNESS OUR SIGNATURES, this
the 19 day of December, 2014. 
  

									
	By:	 	 /s/ Gary Herick
	 		 	By:	 	 /s/ Gerald Crocker

	Name:	 	Gary Herick	 		 	Name:	 	Gerald Crocker
	Company:	 	CannaPharmaRX, Inc.	 		 	Company:	 	CannaPharmaRX, Inc.
	Title:	 	CFO	 		 	Title:	 	CEO
	Date:	 	12-21-2014	 		 	Date:	 	12/18/14

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.com

									
	&	 		 		 		 	
					
	By:	 	 /s/ Troy R. Vanderburg
	 		 	By:	 	 /s/ Terence P. Dolan

	Name:	 	Troy R. Vanderburg	 		 	Name:	 	Terence P. Dolan
	Company:	 	Alternative Investment Store – Division of Benjamin & Jerold Brokerage I, LLC.
	Title:	 	CEO- Alternative Investment Store	 		 	Title:	 	CEO- Benjamin & Jerold Brokerage I, LLC.
	Date:	 	 12/19/2014
	 		 	Date:	 	 12-19-14

  

					
	
Alternative Investment Store – Division of Benjamin & 
Jerold Brokerage I LLC, Member FINRA, SIPC, NYSE, ARCA, & BATS.

	 80 Broad St., 6th Floor New York, NY 10004
	  		  	www.AlternativeInvestmentStore.comEX-10.2

 EXHIBIT 10.2 

CONFIDENTIAL SETTLEMENT AND RELEASE OF CLAIMS AGREEMENT 

THIS CONFIDENTIAL SETTLEMENT AND RELEASE OF CLAIMS AGREEMENT (“AGREEMENT”), effective on the last date executed below, is entered into
between CANNAPHARMARX, INC., a Delaware corporation (“CPRx”), on behalf of itself, its officers, directors, owners, shareholders, employees, attorneys, representatives and agents (in their individual and representative corporate
capacities), and CPRx’s parent, affiliated, predecessor, successor, subsidiary, and other related companies, including Golden Dragon Holding Co., CannaPharmaRX, Inc. (the privately-held Colorado corporation), and CPHR Acquisition Corp., a
Delaware corporation (including their officers, directors, owners, shareholders, employees, attorneys, representatives and agents in their individual and representative corporate capacities), and each of them, jointly and severally (herein
singularly and collectively called “the Company”), and KATHLEEN WOLFF, on behalf of herself and EveryStep Productions, LLC, as well as her heirs, executors, guardians, administrators, successors, and assigns, including Gary S.
Scurka, her former spouse and business partner, and each of them, jointly and severally (herein singularly and collectively called “WOLFF”), who agree to be bound by all of the terms and conditions hereof. 

WHEREAS, between approximately May 2014 through December 31, 2014, WOLFF provided consulting services to the Company through a company named
EveryStep Productions, LLC, of which she is the sole member. 
 WHEREAS, while providing her services to the Company, WOLFF reported to Company
officers, undertook such tasks as specifically requested by such officers, did not set policy, was not present for investment solicitations and, to the Company’s knowledge, did not make any material business decisions that were not specifically
approved by an officer, director, or legal counsel of the Company. 
 WHEREAS, on or about April 28, 2015, CannaPharmaRx, Inc., a privately-held
Colorado company (“CPRx-Colorado”), issued 350,000 Founders Shares of common stock to WOLFF, which were not certificated until on or about June 15, 2014. 

WHEREAS, WOLFF claims to have entered into an Employment Agreement with the Company, which claim the Company denies. 

WHEREAS, WOLFF has alleged various breach of contract, retaliation and constructive termination claims against the Company, which claims the Company
denies. 
 WHEREAS, to avoid any further time commitment or legal expense, the Company and WOLFF (hereinafter collectively referred to herein as
“the Parties”) now wish to resolve and settle amicably any and all of their differences of whatever kind or nature related to WOLFF’s consulting services to and separation from the Company as well as any other claim or matter through
the Effective Date of this Agreement. 

  
 Page 1 

 THEREFORE, in consideration of the mutual covenants and promises set forth in this Agreement, and other
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is hereby agreed by and between the Parties as follows: 

1. Settlement Payment. CPRx agrees to pay WOLFF Fifty Thousand Dollars ($50,000.00) in cash, subject to Form 1099
reporting (the “Settlement Payment”). The Settlement Payment will be paid subject to the following terms and conditions and payment schedule: 
  

	 	(a)	Within three (3) business days of the Effective Date of this Agreement, CPRx will make an initial payment of $30,000.00 as follows—CPRx will pay WOLFF’s company, EveryStep Production, LLC,
$18,000.00 by wire transfer via wire transfer instructions provided by WOLFF, and CPRx will pay $12,000.00 to Morgado, P.A., WOLFF’s legal counsel, to Morgado, P.A.’s operating account and by wire transfer via wire transfer instructions
provided by Morgado, P.A. These payments, along with any payments made under this Agreement, will be subject to Form 1099 reporting to the entities that receive the funds. Therefore, those funds that WOLFF’s legal counsel receives by year end
will be reported via Form 1099 to Morgado, P. A., and those funds that EveryStep Production, LLC receives by year end will be reported via Form 1099 to EveryStep Production, LLC. CPRx will not be reporting funds received by Morgado, P. A. as funds
received by WOLFF or EveryStep Productions, LLC. Morgado P.A. and EveryStep Productions, LLC agree to provide their respective tax ID number, via a signed W-9, and the mailing address along with wire transfer instructions the Settlement Payments and
reporting may be made accurately and timely. 

  

	 	(b)	CPRx will pay the remaining $20,000.00 of the Settlement Payment in five equal monthly installments of $4,000.00—by or on the first business day of each month beginning August 1, 2015, and as follows: CPRx
will pay WOLFF’s company EveryStep Production, LLC $2,400.00 by wire transfer via wire transfer instructions provided by WOLFF, and CPRx will pay $1,600.00 to Morgado, P.A., WOLFF’s legal counsel, to Morgado, P.A.’s operating account
and by wire transfer via wire transfer instructions provided by Morgado, P.A. All such payments will be subject to Form 1099 reporting. 

  

	 	(c)	CPRx agrees to pay WOLFF all remaining unpaid monthly payments in two separate lump-sum payments, broken out in the same percentage amounts set forth above and via wire transfer to WOLFF’s company EveryStep
Production, LLC and Morgado, P.A., via their wire transfer instructions, within ten business days upon CPRx raising an aggregate of Seven Million Dollars and Zero Cents ($7,000,000.00) or more in permanent capital (for the sake of clarity, this
would not include any capital raised via a debt instrument) after the Effective Date of this Agreement. Such payments will be subject to Form 1099 reporting. 

  

	 	(d)	WOLFF and EveryStep Production, LLC acknowledge and agree that they will be responsible for all federal, state, and local tax consequences and obligations related to the foregoing Settlement Payments made to them
and they agree to indemnify, defend and hold harmless the Company from all such tax consequences and obligations for those Settlement Payments they receive. 

2. Forfeiture. If WOLFF breaches any of her obligations under this Agreement, and fails to cure such breach to CPRx’s
reasonable satisfaction within five (5) business days of her receipt of CPRx’s written notice of the breach, CPRx may immediately cease any payments still owed to WOLFF under Paragraph 1 of this Agreement and will be entitled to seek
forfeiture and return by WOLFF, within fourteen (14) business days, of any portions of the Settlement Payment made to WOLFF previously under this Agreement, in addition to any other legal or equitable remedies available to CPRx under this
Agreement or law. Likewise, if the Company breaches any of its obligations under this Agreement, or is late with any payment, and if the Company fails to cure such breach to WOLFF’s reasonable satisfaction within five (5) business days of
receipt of WOLFF’s written notice of the breach, WOLFF may immediately take action against the Company for breach of the Agreement and WOLFF shall be entitled to keep in full any portions of the Settlement Payment WOLFF has received already
under this Agreement. 

  
 Page 2 

 3. Entire Amount of Monetary Consideration. The Parties agree that this
Agreement sets forth the entire amount of monetary and other consideration to which WOLFF is entitled from the Company and that she will not seek any further compensation or monies of any kind or nature from the Company, including but not limited to
back pay, severance pay, front pay, wages, overtime, vacation pay, bonuses, benefits, attorneys’ fees, costs, interest, damages (whether compensatory, punitive or otherwise), business expenses, or other monies. 

4. Termination of Relationship. WOLFF acknowledges that any business, consultancy, or employment affiliation she may have
had with the Company ended as of December 31, 2014. Unless the Company agrees in advance and in writing that WOLFF may submit an application for any consultancy or employment relationship with the Company, WOLFF agrees that she will not apply
for, seek or accept any consultancy or employment relationship with the Company at any time, that the Company shall have no obligation to contract with, employ, or otherwise associate with her in the future, and that this Paragraph represents a
valid, non-discriminatory, non-retaliatory reason to decline to consider her application and to refuse to contract with her, employ, or otherwise associate with her if she acts contrary to this Agreement. 

5. No Use of Wolff Name or Likeness. The Company agrees that it will not intentionally or purposely use or mention
Wolff’s name, image or likeness in any public context in relationship with the Company. This applies to documents, videos, public relations materials, press releases, website materials, investment solicitations, business pitches to investors,
conversations with the media or in any other similar context other than communication regarding this settlement for purposes of accounting. 

6. Representations and Warranties. WOLFF represents and warrants that she has not filed and there are not pending any
charges, claims, suits, complaints or grievances against the Company with any federal, state, local or other governmental agency, or in any court of law, and has not suffered any work-related injury or illness within two years prior to the effective
date of this Agreement. WOLFF acknowledges and agrees that she has been fully and properly paid for all hours in which she provided services to the Company. WOLFF has requested and received such information in connection with the execution of
this Agreement as she believes to be necessary in order to make an informed decision to enter into this Agreement and to bind herself as set forth herein, and she has had an opportunity to discuss this information with her own advisors and
consultants and obtain answers to any questions that she may have had. WOLFF further waives any claims for fraudulent inducement based on any misrepresentations or omissions by the Company in connection with this Agreement. In addition, the Company
represents and warrants that its contract with EveryStep Productions LLC for the documentary film originally commissioned by Gary Herick and Malcom Gray, whose obligations and rights were later transferred to CannaPharmaRx but which was never signed
by Mr. Gray, is void. as between the Company and EveryStep Productions (contract is attached to this Agreement as Exhibit A). WOLFF and/or EveryStep Productions and its current and/or affiliates or future partners and affiliates have no
obligations to the Company regarding the contract. 
 7. Covenant Not to Sue. WOLFF agrees not to file any charges,
claims, suits, complaints, or grievances against the Company with respect to any aspect of her affiliation with, or separation from, the Company, or with respect to any other matter whatsoever, whether known or unknown to her at the time of
execution of this Agreement, with the exceptions of: (a) any claim that the Company breached its commitments or any representations under this Agreement; and (b) any claims that the law precludes her from waiving by agreement. 

8. Covenant Not to Sue. The Company agrees not to file any charges, claims, suits, complaints, or grievances against the
WOLFF or EveryStep Productions LLC with respect to any aspect of its affiliation with, or separation from, WOLFF, or with respect to any other matter whatsoever, whether known or unknown to her at the time of execution of this Agreement, with the

  
 Page 3 

 
exceptions of: (a) any claim that WOLFF breached her commitments under this Agreement; and (b) any claims that the law precludes it from waiving by agreement. SINCE THE COMPANY IS
GIVING HER A RELASE OF CLAIMS IN PARAGRAPH 8.(b) BELOW, I AM OKAY WITH MAKING THIS COVENANT MUTUAL. 
 9. Release of
Claims. 
 (a) Release by WOLFF. WOLFF acquits, releases, and forever discharges the Company of and from all, and in all
manner of, actions and causes of action, suits, debts, claims, and demands whatsoever, in law or in equity, which she ever had, or may now have, with respect to any aspect of her affiliation with the Company, or with respect to any other matter
whatsoever, whether known or unknown to her at the time of execution of this Agreement, including, but not limited to, claims for compensatory, actual, special, consequential, reliance, punitive, exemplary and/or other damages, including but not
limited to claims for personal injuries, pain and suffering, emotional distress, health care expenses, back pay, front pay, separation pay, wages, benefits, attorney’s fees, costs, interest, other monies, but excluding: (i) any claim for
breach of this Agreement; and (ii) any claims the law precludes her from waiving by agreement. 
 (b) Release by the Company. The
Company acquits, releases, and forever discharges WOLFF, including EveryStep Productions, of and from all, and in all manner of, actions and causes of action, suits, debts, claims, and demands whatsoever, in law or in equity, which the Company ever
had, or may now have, with respect to any aspect of its affiliation with WOLFF and/or EveryStep Productions, or with respect to any other matter whatsoever, whether known or unknown to the Company at the time of execution of this Agreement,
including, but not limited to, claims for compensatory, actual, special, consequential, reliance, punitive, exemplary and/or other damages, including but not limited to claims for attorney’s fees, costs, or interest, but excluding: (a) any
claim for breach of this Agreement; and (b) any claims the law precludes from waiving by agreement. 
 10. Laws Included in
Release. WOLFF agrees that with the exception of any action for breach of this Agreement or that the law precludes her from waiving by agreement, her covenants and releases, as set forth in this Agreement, include a waiver of any and all
rights or remedies which she ever had or may now have against the Company under any present or future federal, state, or local statute or law, including, but not limited to the Constitutions of the United States and the State of New Jersey,
including its civil rights laws, its wage and equal pay laws, its whistleblower laws, its workers’ compensation laws, and any other claims for unpaid or delayed payment of any monies allegedly owed to WOLFF, as well as under Title VII of the
Civil Rights Act of 1964, 42 U.S.C. §2000e, et seq.; the Civil Rights Act of 1866, 42 U.S.C. §1981; the Civil Rights Act of 1991, PL. 102-166; the ADEA and the Older Workers Benefit Protection Act, 29 U.S.C. §621, et
seq.; the Americans with Disabilities Act, 42 U.S.C. §12101, et seq.; the FLSA and the Equal Pay Act of 1963, 29 U.S.C. §201, et seq.; the FMLA; the Employee Retirement Income Security Act, 29 U.S.C. §1001, et
seq.; the Occupational Safety and Health Act of 1970, 29 U.S.C. §553, et seq.; the National Labor Relations Act, 29 U.S.C. §141, et seq.; COBRA; and any statutory amendments. 

11. Waiver of Unknown Claims. The Parties intend that this Agreement shall bar each and every claim, demand, and cause of
action hereinabove specified, whether known or unknown to them at the time of execution of this Agreement. As a result, they acknowledge that they might, in the future, discover claims or facts in addition to or different from those which they now
know or believe to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this Agreement, may have materially affected this settlement. Nevertheless, the Parties waive any right, claim,
or cause of action that might arise as a result of such different or additional claims or facts. 

  
 Page 4 

 12. Mutual Non-Disparagement and Non Admission. The Company and WOLFF agree
not to make, publish or communicate publicly any false or intentionally disparaging remarks or statements about the other. For the Company and its related entities, such obligation will only apply to their then directors and officers while they are
holding such positions with the Company. and that only the corporate entity, and not any individual officer or director, will be subject to breach of contract liability for a violation of this obligation under this Agreement. The Parties also agree
that neither is admitting to any liability owed to the other. 
 13. Confidential Information and Trade Secrets. WOLFF
acknowledges that the confidential information and trade secrets of the Company, including business and financial information, plans, ideas, programs, designs, drawings, methods, materials, equipment, customer lists, inventions, processes, files,
materials, and the like, are valuable assets of the Company, the disclosure of which to those outside the Company could cause immediate and irreparable harm to the Company. WOLFF therefore agrees that except upon the prior written consent from the
Company, she will not use, convey, or disclose to any person, corporation or entity any such confidential information or trade secrets that she may have acquired or gained access to while she was associated with the Company. 

14. Non-Interference with WOLFF’s Legally Protected Rights. The Company and WOLFF understand and agree that nothing
in this Agreement interferes with or in any way restricts the Parties’ legal rights to participate or cooperate truthfully in any inquiry, investigation or proceeding by any federal, state or local government agency charged with the enforcement
of any laws. The Company and WOLFF agree that nothing in any provisions of this Agreement prohibit or restrict WOLFF from communicating with the SEC, the DOL, or any other governmental authority, making a report in good faith and with a reasonable
belief of any violations of law or regulation to a governmental authority, or cooperating with or participating in a legal proceeding relating to any such violation. The Company and WOLFF agree, however, that WOLFF is releasing and waiving any right
or demand to recover for herself (as WOLFF is defined in this Agreement) and from the Company any monetary damages, award, or other legal or equitable relief in connection with any such inquiry, investigation, or proceeding. 

15. Return of Company Property. By or before the Effective Date of the Agreement, WOLFF shall return to the Company, in a
manner and at a location as the Company directs, all property of the Company of any kind in her possession or under her control, including but not limited to all computers, laptops, computer passwords, phones, keys, credit cards, book displays,
marketing materials), and any hard copies and electronic business records. By signing this Agreement, WOLFF acknowledges that she has not kept possession of, or deleted, destroyed, encrypted, downloaded, emailed, or copied, any of the Company’s
electronic business information for any other purpose than to protect herself from any possible false claims in the future and has not and will not provide any such materials to any other person or persons other than 1.) her attorneys and 2.) those
involved in an inquiry, investigation or proceeding by any federal, state or local government agency charged with the enforcement of any laws. Except as permitted in this paragraph, WOLFF agrees to be bound to the Confidential Information and
Returning Company Documents obligations set forth in Sections 7.A and 7. B. of Exhibit B attached hereto and which are incorporated “as is” into this Agreement. 

16. Cooperation in Legal Matters. WOLFF agrees that upon reasonable notice from government authorities, she will make
herself available and cooperate with and assist, in connection with any proceeding before a federal, state, or local governmental agency, or in any arbitration or court of law, pertaining to any matter for which she has knowledge or information as a
result of her affiliation with the Company. In the event that a subpoena or other lawful process is properly served on WOLFF 

  
 Page 5 

 
requiring production or disclosure of information or documents concerning her or EveryStep Productions’ knowledge of or services to the Company, WOLFF or her legal counsel shall promptly
notify the Company’s President in writing and will provide the President with copies of any subpoena or other process served on WOLFF or EveryStep Productions. WOLFF and/or EveryStep Productions shall thereafter make such documents available,
at the Company’s expense and prior to their production, for inspection and copying by the Company at a reasonable time and place designated by the Company. 

17. Adequate Consideration. WOLFF agrees that the covenants and promises made by her in this Agreement are in
consideration of the payment and other promises made hereunder by the Company, which she acknowledges to be sufficient, just and adequate consideration for her covenants and promises. WOLFF further acknowledges that, but for her execution of this
Agreement, she would not be entitled to the Settlement Payment being provided to her under this Agreement. 
 18.
Non-Disclosure. The Parties agree not to disclose the terms of this Agreement publicly except as may be required by law, in any SEC filing or other similarly required public disclosure or release, or as the Company may reasonably
need to do so for business purposes (such as in a discussion with a future investor or shareholder, etc.). WOLFF agrees not to disclose the terms of the Agreement to anyone other than her counsel, tax or financial advisors, immediate family members
(spouse, children and parents), subject to each of their respective agreements to keep the terms strictly confidential and to not disclose the terms to any other person or entity. 

19. Relief for Breach. The Parties agree that if either Party at any time asserts that any of the terms of this Agreement
have been violated, that Party shall have the right to seek specific performance of such term or terms, appropriate injunctive relief to prevent a breach of the term or terms, and any other necessary and proper relief, including monetary damages,
from any court of competent jurisdiction, and that the Prevailing Party (by court judgment, order, verdict or a private settlement) shall be entitled to recover their reasonable costs (including expert witness fees and discovery costs), expenses and
attorney’s fees incurred in connection with any such legal and/or equitable action. 
 20. Governing Law and
Interpretation. The Parties agree that this Agreement shall be construed in accordance with New Jersey law, that any action brought by any Party hereunder shall be instituted and maintained only in the appropriate federal or state court
located in New Jersey where the Company maintains its headquarters, and that the Parties consent and agree to the personal jurisdiction and subject matter jurisdiction of either such court, and that this Agreement shall be interpreted in accordance
with the plain meaning of its terms and not strictly for or against any Party. 
 21. Modification, Waiver and Assignment.
This Agreement shall not be changed, modified, terminated, canceled or amended except by a written instrument signed by both the Company and WOLFF. The failure to exercise or a delay in exercising, any right, remedy or power under this
Agreement shall not operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy or power under this Agreement preclude any other or further exercise thereof. The Parties agree that the Company, but not WOLFF, may
assign its rights and obligations under this Agreement without notice to or consent from WOLFF. 

  
 Page 6 

 22. Notices. Any notices required or permitted to be given
under this Agreement shall be in writing, sent by certified or registered mail, as follows: 
  

			
	 To WOLFF:
	  	To the Company:
		
	 Kathleen Wolff
 3900 Fairfax Drive – Apt
1001
 Arlington, VA 22203
	  	 CannaPharmaRx, Inc.
 Attn: President

1 Collins Drive Suite 100
 Carney’s Point, NJ
08069-3640

 23. Headings and Electronic Signature. The headings used in this Agreement are
descriptive only, are for the convenience of identifying provisions, and are not determinative of the meaning or effect of any provision. The parties agree that hard copy and electronic copies of their signatures to this Agreement shall be deemed
original signatures. 
 24. Entire Agreement. The Parties agree that this Agreement, together with its Exhibits,
constitute the entire agreement between them and that except to the extent referred to herein or incorporated herein by reference, there exist no other agreements, oral or written, express or implied, relating to any matters covered by this
Agreement, or relating to any other matter whatsoever, whether or not within the knowledge or contemplation of any of the Parties at the time of execution of this Agreement. For avoidance of doubt, any transactions involving the Company which
relates to or affects WOLFF’s Founder Shares of common stock in CannaPharmaRx, Inc., a Colorado corporation, or its parent or any affiliate, are outside the scope of this Agreement. 

25. Acknowledgement. WOLFF acknowledges and agrees: 

 

	 	(a)	She has had more than ample time within which to review and consider signing this Agreement; 

  

	 	(b)	She was advised and hereby is advised in writing to consult with an attorney of her choice (namely Dale James Morgado, Esq.), at her expense, prior to signing this Agreement; 

 

	 	(c)	She has read the terms of this Agreement, she agrees that this Agreement is written clearly and with language she understands, and she has knowingly, voluntarily and of her own free will agreed to the terms of
this Agreement for the purpose of fully and finally compromising and settling any and all claims, disputed or otherwise, of any kind or nature that she ever had or may now have against the Company arising out of her association with and/or
separation from the Company, and arising out of any other matter, whether known or unknown to her at the time of execution of this Agreement; 

  

	 	(d)	She is not waiving any claims or rights that may arise after the execution of this Agreement under the ADEA, or otherwise; 

26. Effective Date. The Parties agree that the Effective Date of this Agreement shall be the last date that a Party to this
Agreement enters its/her signature to this Agreement. 

  
 Page 7 

 WHEREFORE, the Parties have read all of the foregoing, understand the same, and agree to all of the
provisions contained herein. 
  

									
	CANNAPHARMARX, INC. (“CPRx”)	 		 	KATHLEEN WOLFF
					
	By:	 	 /s/ Gerry Crocker
	 		 	By:	 	 /s/ Kathleen Wolff

		 		 		 		 	Kathleen Wolff, including for and on behalf of EveryStep Productions, LLC
	Its:	 	CEO	 		 		 	
					
	Dated:	 	7/10/15	 		 	Dated:	 	7/9/15

 THE COMPANY AS DEFINED IN THIS AGREEMENT, INCLUDING GOLDEN DRAGON HOLDING CO., CANNAPHARMARX, INC. (THE PRIVATELY HELD
COLORADO CORPORATION), AND CPHR ACQUISITION CORP. 
  

			
	By:	 	 /s/ Gerry Crocker

	Its:	 	  

		 	Authorized Representative
		
	Dated:	 	7/10/15

  
 Page 8 

 EXHIBIT A 
  

 
 CONTRACTUAL AGREEMENT 

Between EveryStep Productions LLC and Producers Gary Herick and J. Malcom Gray 

This agreement relates to a documentary film of approximately 60-90 minutes in length whose focus is to record the formation of the company CannaPharmaRx Inc.
The film is commissioned by Gary Herick, PO Box 5035, Edwards, Colorado, 81632 and J. Malcom Gray, 5100 Westheimer, Ste 540, Houston TX 77056 (Producers). 

The film company is EveryStep Productions LLC, co-owned by Gary S. Scurka and Kathleen P. Wolff, 1400 Key Boulevard, Suite 100, Rosslyn, Virginia 22209
(Filmmakers). 
 Filmmakers and Producers agree that the following provisions incorporated into the contract to make the film, said contract being signed
and dated May 13, 2014. Filmmakers and Producers agree that the terms of this agreement prevail over the terms of any other document relating to the referenced Work. 

SCOPE OF WORK 
 Producers desire to have certain services
and tasks performed as set forth below requiring the specialized skills, talents and other expertise of the Filmmakers. The completed results and product of the Filmmakers’ services shall be deemed the “Work.” The Work is specially
ordered and commissioned by Producers for use in connection with the “Film” tentatively titled: “CannaPharmaRx” 
 The work to be
performed by Filmmakers includes following and recording the activities of the founders of CannaPharmaRx as they build a pharmaceutical company which will manufacture and distribute pharmaceutical-grade medical marijuana products. The 60+ minute
documentary will follow traditional documentary practices of recording events in real time, i.e., as they happen while simultaneously filming complementary images and interviews for context. 

PURPOSE OF THE FILM 
 The film is being created for
commercial purposes which may include any or all of the following: distribution for theatrical release, television broadcast, film festivals, online viewing and distribution via DVDs. Producers and Filmmakers agree they will promote the film through
their own best efforts. Some expenses for the film will be paid by CannaPharmaRx in exchange for limited use of the raw footage for the creation of short films targeted toward investors of approximately 3-7 minutes in length. Some expenses may also
be paid by the non-profit industry association, National Association of Cannabis Pharmacy (NACP) in exchange for brief videos to be used on its website for educational purposes. No other use of the film’s raw footage is permitted without the
express written consent of Producers. 

 COMPLETION DATE 

Producers must complete their contributions by December 1, 2014. Filmmakers agree to provide Producers with rough cut edit by December 31,
2014. Following Producers’ comments and any suggested changes; post production be completed by March 1, 2015. In the event Producers wish to include CannaPharmaRX
developments that may arise past the December 1 deadline, Filmmakers and Producers will mutually agree on how to fund the project and extend deadlines accordingly. 

If either of the parties fails to make a deadline for any reason, the Filmmakers and Producers will mutually agree, in writing, to extend the time for
completion. Filmmakers will not be held responsible if, for reasons out of the Filmmakers’ control, including death, injury, acts of God or nature, the film is not completed time. 

CREDIT 
 The Work shall contain the following credits:
“Produced by Gary Herick and J. Malcom Gray,” “a Film by EveryStep Productions LLC,” “Directed by Gary Scurka,” “Director of Photography, Gary Scurka,” “Written by Kathleen Wolff and Gary Scurka,”
“Narrated by Kathleen Wolff” and credits to other contributors pending. 
 DECISION MAKING 

Business and other decisions affecting the Work shall be made jointly by Producers and Filmmakers. No sale, disposition, licensing or other agreement with a
third party shall be valid without the written consent of the Producers and Filmmakers. 
 PAYMENTS 

Producers agree to provide $80,000 in funding for the film, of which $30,000 will be paid to the Filmmakers in sums of $5,000 per month for 6 months on the
following schedule: 
 June 1, 2014 (rescheduled to due June 15, 2014) 

July 1, 2014 
 August 1, 2014 

September 1, 2014 
 October 1, 2014 

December 1 2014 
 Of the remaining $50,000, approximately
$30,000 will be allocated for post-production, music and insurance. The remaining approximately $20,000 will be allocated for travel. A detailed budget is attached to this agreement. 

In lieu of the funding provided, the Producers are entitled to 80% of all receipts generated by the film, including ticket sales, domestic and overseas
distribution, DVD and merchandising. Ownership is detailed in the chart below. 

					
	 Name of Member
	  	Approximate % Ownership	 
	 GARY HERICK
	  	 	40	% 
	 J. MALCOLM GRAY
	  	 	40	% 
	 EVERYSTEP PRODUCTIONS, LLC
	  	 	20	% 

 Any subsequent movie rights will be split between the Producers and Filmmakers, 50/50. 

Any tax information or other documents related to this agreement be exchanged directly between Producers and Filmmakers. Filmmakers agree to submit expense
records for reimbursement within 30 days of the incurred expenses and Producers agree to reimburse those expenses within 30 days of filing official paperwork, Payments to Filmmakers should be made payable to EveryStep Productions LLC, E.J.N.
46-3387164, and mailed to 1400 Key Blvd Suite 100, Rosslyn Virginia, 22209. 
 NO PARTNERSHIP 

Filmmakers and Producers are collaborating on this single Work. This agreement does not create a legal partnership relationship. 

WARRANTIES AND INDEMNITIES 
 Producers and Filmmakers
represent and warrant to each other that each is free to enter into this agreement, all contributions to the Work are original or all necessary permissions and releases will be obtained and paid for, and no intellectual property rights will be
infringed upon or other laws violated. Errors and omissions insurance will be purchased with the funds provided for the film. However, Producers accept full responsibility for any legal fees required in connection with the production or showing of
the film, including response to any legal inquiry or action that may arise related to the Work. 
 ASSIGNMENT, ENTIRETY OF AGREEMENT, GOVERNING,
JURISDICTION AND MEDIATION 
 This agreement cannot be assigned or transferred without the written consent of the Filmmakers and Producers. This
agreement constitutes the entire agreement between the Filmmakers and Producers. No modification shall be enforceable except in writing and signed by the Filmmakers and Producers hereto. This agreement shall be governed by the laws of the state of
Virginia. In the event any dispute arising under this agreement results in litigation, arbitration or mediation, such action or proceeding shall be brought within the state or federal courts of Virginia. 

SEVERABILITY 
 If any provision of this agreement or the
application thereof is held invalid, the invalidity shall not affect other provisions or application of this agreement which can be given effect without the invalid provisions or application, and to this end the provisions of this agreement are
declared to be servable. 

									
	Signature:	 	 /s/ Kathleen P. Wolff
	 		 	Signature:	 	 /s/ Gary Herick

	Printed Name:	 	Kathleen P. Wolff, MFA	 		 	Printed Name:	 	Gary Herick
	Date:	 	June 9, 2014	 		 	Date:	 	6-9-14

 

 
 CONTRACTUAL AGREEMENT ADDENDUM 

Between EveryStep Productions LLC, CannaPharmaRx, Inc. 

and Producers Gary Herick and J. Malcom Gray 

This addendum relates to the agreement regarding a documentary film of approximately 60-90 minutes in length whose focus is to record the formation of the
company CannaPharmaRx Inc. The film, originally commissioned by Gary Herick, PO Box 5035, Edwards, Colorado 81632 and J. Malcom Gray, 5100 Westheimer, Ste-540, Houston TX 77056
(“Producers”). 
 The film company is EveryStep Productions LLC, co-owned by Gary S. Scurka and Kathleen P. Wolff, 1400 Key Boulevard, Suite 100,
Rosslyn, Virginia 22209 (“Filmmakers”). A new party to the agreement is CannaPharmaRx, Inc. (“Company”) located at 1 Collins Drive, Suite 100 Carney’s Point NJ 08069. 

Filmmakers and Producers agree that the rights and obligations of Producers being transferred entirely to the Company. All of the provisions incorporated into
the contract to make the film, said contract being originally signed and dated May 13, 2014 remain the same with the following exceptions: 

PURPOSE OF THE FILM 
 The National Association of Cannabis
Pharmacy (NACP), which was established through funding from CannaPharmaRx, will have no rights to this project for any purpose as the brief videos commissioned for its website were cancelled at its request and at the date of this addendum, the
organization and its website no longer exist. 
 COMPLETION DATE 

The completion date is now at the discretion of CannaPharmaRx and EveryStep Productions. Parties agree that the delivery date for a completed piece may be well
into the future after the Company achieves a high degree of profitability and public recognition. 
 CREDIT 

The Work shall contain no credits to the original Producers. 

PAYMENTS 
 While all payments and fees are the same, the
ownership chart is modified below for avoidance of doubt. 

					
	 Name of Member
	  	Approximate %
Ownership	 
	 CANNAPHARMARX, INC.
	  	 	80	% 
	 EVERYSTEP PRODUCTIONS LLC
	  	 	20	% 

 ASSIGNMENT, ENTIRETY OF ADDENDUM AND AGREEMENT 

This addendum and agreement cannot be assigned or transferred without the written consent of the Filmmakers and Company. This addendum combined with the
original agreement constitutes the entire agreement between the Filmmakers and Company. No modification shall be enforceable except in writing and signed by the Filmmakers and Company hereto. 

 

									
	Signature:	 	 /s/ Kathleen P. Wolff
	 		 	Signature:	 	 /s/ Gary Herick

	Printed Name:	 	Kathleen P. Wolff, EveryStep LLC	 		 	Printed Name:	 	Gary Herick
	Date:	 	December 3, 2014	 		 	Date:	 	December 3, 2014
					
	Signature:	 	  
	 		 	Signature:	 	 /s/ Gerry Crocker

	Printed Name:	 	Malcolm Gray	 		 	Printed Name:	 	Gerry Crocker, CannaPharmaRx
	Date:	 	December 3, 2014	 		 	Date:	 	December 3, 2014

 EXHIBIT B 

7. Confidentiality, Return of Property, and Covenant Not to Compete. 

A. Confidential Information. 

(1) Company Information. The Company agrees that it will provide the Executive with Confidential Information, as defined below, that
will enable the Executive to optimize the performance of the Executive’s duties to the company. In exchange, the Executive agrees to use such Confidential Information solely for the Company’s benefit. The Company and the Executive agree
and acknowledge that its provision of such Confidential Information is not contingent on the Executive’s continued employment with the company. Notwithstanding the preceding sentence, upon the termination of the Executive’s employment for
any reason, the Company shall have no obligation to provide the Executive with its Confidential Information. “Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but
not limited to, research, product plans, products services, customer lists and customers (including, but not limited to, customers of the Company on whom the Executive called or with whom the Executive became acquainted during the term of the
Executive’s employment), markets, software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing finances or other business information disclosed to the
Executive by the Company either directly or indirectly in writing, orally or by drawings or observation of parts or equipment. Confidential Information does not include any of the foregoing items which has become publicly known and made generally
available through no wrongful act of the Executive or of others who were under confidentiality obligations as to the item or items involved or improvements or new versions. 

The Executive agrees at all times during the Term and thereafter, to hold in strictest confidence, and not to use, except for the exclusive
benefit of the Company, or to disclose to any person or entity without written authorization of the Board of Directors of the Company, any Confidential Information of the Company. 

(2) Former Employer Information. The Executive agrees that he will not, during her employment with the Company, improperly use or
disclose any proprietary information or trade secrets of any former employer or other person or entity and that the Executive will not bring onto the premises of the Company any unpublished document or proprietary information belonging to any such
employer, person or entity unless consented to in writing by such employer, person or entity. 
 (3) Third Party Information. The
Executive recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s party to maintain the confidentiality of such information and
to use it only for certain limited purposes. The Executive shall hold all such confidential or proprietary information in the strictest confidence and not disclose it to any person or entity or use it except as necessary in carrying, out the
Executive’s work for the Company consistent with the Company’s agreement with such third party. 

 B. Returning Company documents. At the time of leaving the employ of the Company, the
Executive will deliver to the Company (and will not keep in the Executive’s possession) specifications, drawings blueprints, sketches, materials, equipment, other documents or property, or reproductions of any aforementioned items developed by
the Executive pursuant to the Executive’s employment with the Company or otherwise belonging to the Company, its successors or assigns.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}]]